ANI Pharmaceuticals (ANIP)

[jeffqdhsr]

Thanks for post JTFM

As it related to ANIP acquiring Bpax , outside of roughly 18 million in cash to date what exactly has Bpax contributed to the value of ANIP ? Both Libigel & Gvax remain " unrealized assets " a sale prior to shareholder s being informed could undermine a fair sale that take these particular assets into account !!

Point being , and it's important for other investors that are new, that there are currently patent applications that make the assertion within those pending applications that amongst other benefits " Libigel can reduce CV events by 70% !!! Their finding s that support these patent pending applications is the Safety Study conducted by Biosante that was a approved study and continued for 5 years ending sometime in 2016 ?? To date investors have been left in the dark as to what their findings are in the extended safety study , ANI to my knowledge has not reported any results regarding same. JMHO